Related references
Note: Only part of the references are listed.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease
Natalia Ingrid Oliveira Silva et al.
VIROLOGY JOURNAL (2020)
COVID-19 vaccines: breaking record times to first-in-human trials
Young Chan Kim et al.
NPJ VACCINES (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Preparing for Pandemics: RNA Vaccines at the Forefront
Jesse H. Erasmus et al.
MOLECULAR THERAPY (2020)
Amplifying RNA Vaccine Development
Deborah H. Fuller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Distinct YFV Lineages Co-circulated in the Central-Western and Southeastern Brazilian Regions From 2015 to 2018
Edson Delatorre et al.
FRONTIERS IN MICROBIOLOGY (2019)
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
Ismael Artur da Costa-Rocha et al.
FRONTIERS IN IMMUNOLOGY (2019)
Estimating Past, Present, and Future Trends in the Global Distribution and Abundance of the Arbovirus Vector Aedes aegypti Under Climate Change Scenarios
Jing Liu-Helmersson et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Viral Hemorrhagic Fevers in Pregnant Women and the Vaccine Landscape: Comparisons Between Yellow Fever, Ebola, and Lassa Fever
Carleigh B. Krubiner et al.
CURRENT TROPICAL MEDICINE REPORTS (2019)
Management and control of yellow fever virus: Brazilian outbreak January-April, 2018
David Michael Callender
GLOBAL PUBLIC HEALTH (2019)
Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses
Jose V. J. Silva et al.
ACTA TROPICA (2018)
Yellow fever: a major threat to public health
The Lancet
LANCET (2018)
Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe
Florian Douam et al.
TRENDS IN MICROBIOLOGY (2018)
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
Cesar Lopez-Camacho et al.
NATURE COMMUNICATIONS (2018)
Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients
Nathalie Colin de Verdiere et al.
AIDS (2018)
Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
Alexander Nikolay et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model
Justin G. Julander et al.
FRONTIERS IN IMMUNOLOGY (2018)
Long-Term Protection After Fractional-Dose Yellow Fever Vaccination Follow-up Study of a Randomized, Controlled, Noninferiority Trial
Anna H. E. Roukens et al.
ANNALS OF INTERNAL MEDICINE (2018)
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
Dimitrios Gouglas et al.
LANCET GLOBAL HEALTH (2018)
Yellow fever vaccine and risk of developing serious adverse events: a systematic review
Ruben Porudominsky et al.
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
Yellow fever vaccination: estimating coverage
Annelies Wilder-Smith
LANCET INFECTIOUS DISEASES (2017)
Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease
Alan D. T. Barrett
VACCINE (2017)
Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day
Natalie D. Collins et al.
CURRENT INFECTIOUS DISEASE REPORTS (2017)
Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology
Lalita Priyamvada et al.
EMERGING MICROBES & INFECTIONS (2017)
Progress and Works in Progress: Update on Flavivirus Vaccine Development
Matthew H. Collins et al.
CLINICAL THERAPEUTICS (2017)
Yellow fever vaccine: worthy friend or stealthy foe?
Stephen J. Seligman et al.
EXPERT REVIEW OF VACCINES (2016)
DNA-launched live-attenuated vaccines for biodefense applications
Peter Pushko et al.
EXPERT REVIEW OF VACCINES (2016)
Modelling a way out of yellow fever
Leo G. Visser et al.
LANCET (2016)
Yellow fever vaccine supply: a possible solution
Thomas P. Monath et al.
LANCET (2016)
Yellow fever: a global reckoning
[Anonymous]
LANCET (2016)
Fractional dosing of yellow fever vaccine to extend supply: a modelling study
Joseph T. Wu et al.
LANCET (2016)
Yellow Fever in Angola and Beyond - The Problem of Vaccine Supply and Demand
Alan D. T. Barrett
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Current status and future prospects of yellow fever vaccines
Andrew S. Beck et al.
EXPERT REVIEW OF VACCINES (2015)
Cracking the egg: An insight into egg hypersensitivity
Pathum Dhanapala et al.
MOLECULAR IMMUNOLOGY (2015)
An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
Renata C. Pereira et al.
VACCINE (2015)
A DNA Vaccine against Yellow Fever Virus: Development and Evaluation
Milton Maciel et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus
Moritz U. G. Kraemer et al.
ELIFE (2015)
Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone
Xiaohong Jiang et al.
JOURNAL OF GENERAL VIROLOGY (2015)
A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available
Tomohiro Ishikawa et al.
VACCINE (2014)
Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice
Irina Tretyakova et al.
VIROLOGY (2014)
Pre-existing immunity against Ad vectors Humoral, cellular, and innate response, what's important?
Hugues Fausther-Bovendo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Review Article: Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years
Eduardo Gotuzzo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
The Immunosuppressed Traveler
L. G. Visser
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2012)
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Matthew D. J. Dicks et al.
PLOS ONE (2012)
Viral vectors as vaccine platforms: deployment in sight
Christine S. Rollier et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
An Inactivated Cell-Culture Vaccine against Yellow Fever
Thomas P. Monath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever
Birgit Schaefer et al.
PLOS ONE (2011)
Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model
Justin G. Julander et al.
VACCINE (2011)
Yellow Fever: A Reemerging Threat
Christina L. Gardner et al.
CLINICS IN LABORATORY MEDICINE (2010)
Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity
Thomas P. Monath et al.
VACCINE (2010)
Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
Alan D. T. Barrett et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Yellow fever: 100 years of discovery
J. Erin Staples et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Adverse event reports following yellow fever vaccination
Nicole P. Lindsey et al.
VACCINE (2008)
The prevalence of food allergy: A meta-analysis
Roberto J. Rona et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
1918 influenza: the mother of all pandemics
JK Taubenberger et al.
EMERGING INFECTIOUS DISEASES (2006)
New developments in flavivirus vaccines with special attention to yellow fever
KV Pugachev et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2005)
Broadening the horizons for yellow fever: new uses for an old vaccine
HL Van Epps
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Shortage of vaccines during a yellow fever outbreak in Guinea
N Nathan et al.
LANCET (2001)
Share Paper
